- Home
- EVAX vs GURE Comparison
EVAX vs GURE Comparison
Compare EVAX & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- GURE
- Stock Information
- Founded
- EVAX 2008
- GURE 2006
- Country
- EVAX Denmark
- GURE China
- Employees
- EVAX N/A
- GURE N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- GURE Major Chemicals
- Sector
- EVAX Health Care
- GURE Industrials
- Exchange
- EVAX Nasdaq
- GURE Nasdaq
- Market Cap
- EVAX 8.7M
- GURE 7.1M
- IPO Year
- EVAX 2021
- GURE 1992
- Fundamental
- Price
- EVAX $2.41
- GURE $0.70
- Analyst Decision
- EVAX Strong Buy
- GURE
- Analyst Count
- EVAX 2
- GURE 0
- Target Price
- EVAX $11.00
- GURE N/A
- AVG Volume (30 Days)
- EVAX 250.1K
- GURE 258.8K
- Earning Date
- EVAX 10-31-2024
- GURE 11-19-2024
- Dividend Yield
- EVAX N/A
- GURE N/A
- EPS Growth
- EVAX N/A
- GURE N/A
- EPS
- EVAX N/A
- GURE N/A
- Revenue
- EVAX $3,295,000.00
- GURE $12,802,982.00
- Revenue This Year
- EVAX $4,845.21
- GURE N/A
- Revenue Next Year
- EVAX $30.30
- GURE N/A
- P/E Ratio
- EVAX N/A
- GURE N/A
- Revenue Growth
- EVAX N/A
- GURE N/A
- 52 Week Low
- EVAX $2.38
- GURE $0.50
- 52 Week High
- EVAX $68.05
- GURE $1.79
- Technical
- Relative Strength Index (RSI)
- EVAX 23.50
- GURE 52.07
- Support Level
- EVAX $2.38
- GURE $0.55
- Resistance Level
- EVAX $3.90
- GURE $0.78
- Average True Range (ATR)
- EVAX 0.51
- GURE 0.16
- MACD
- EVAX -0.05
- GURE 0.00
- Stochastic Oscillator
- EVAX 2.72
- GURE 14.52
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.